Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

PF-06700841

OTHER

Placebo

Trial Locations (44)

10065

The Rockefeller University, New York

14623

Skin Search of Rochester, Inc., Rochester

23502

Virginia Clinical Research, Inc., Norfolk

27514

Investigational Drug Services, UNC Hospitals, Chapel Hill

27516

UNC Dermatology and Skin Cancer Center, Chapel Hill

27599

UNC Clinical and Translation Research Center, Chapel Hill

32073

Park Avenue Dermatology Administrative Annex, Orange Park

Park Avenue Dermatology, Orange Park

33609

Olympian Clinical Research, Tampa

Rose Radiology, Tampa

33624

Forward Clinical Trials, Inc, Tampa

46256

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

Dawes Fretzin Dermatology Group, LLC, Indianapolis

57702

Health Concepts, Rapid City

60118

Dundee Dermatology, West Dundee

72758

Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA, Rogers

73112

Lynn Health Science Institute, Oklahoma City

74136

Vital Prospects Clinical Research Institute, P.C, Tulsa

77004

Center for Clinical Studies, Houston

78213

Lee Medical Associates, PA, San Antonio

Progressive Clinical Research, PA, San Antonio

78218

Texas Dermatology and Laser Specialists, San Antonio

90403

Tower Saint John's Imaging, Santa Monica

90404

Clinical Science Institute, Santa Monica

92024

California Dermatology & Clinical Research Institute, Encinitas

92701

Southern California Dermatology, Santa Ana

92801

Anaheim Clinical Trials, LLC, Anaheim

95819

Emil A. Tanghetti, MD dba Center for Dermatology and Laser Surgery, Sacramento

99202

Premier Clinical Research, Spokane

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

R3M 3Z4

Wiseman Dermatology Research Inc., Winnipeg

L3P 1X2

Lynderm Research Inc, Markham

L6J 7W5

Research by ICLS, Oakville

K9J 5K2

Skin Centre for Dermatology, Peterborough

L4B 1A5

The Centre for Dermatology, Richmond Hill

N2J 1C4

K.Papp Clinical Research Inc., Waterloo

G1V4X7

Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Québec

J1L 0H8

Diex Research Sherbrooke Inc., Sherbrooke

80-266

Centrum Medyczne Enel-Med Przychodnia Grunwaldzka, Gdansk

80-546

Centrum Badan Klinicznych PI-House Sp. z o.o., Gdansk

90-436

Dermoklinika Centrum Medyczne s.c. M.Kierstan, J. Narbutt, A. Lesiak, Lodz

87-100

"NZOZ Nasz Lekarz - Praktyka Grupowa Lekarzy Rodzinnych z Przychodnia Specjalistyczna", Torun

02-106

MTZ Clinical Research Sp. z o.o., Warsaw

51-685

WroMedica s.c., Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02969018 - Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter